Clinical - Phase News: Breaking Clinical - Phase News, Comments and Articles.

R-Tech Ueno: Start of the Patient Enrollment of a Phase I/II Clinical Study of Recombinant Human Serum Albumin-Containing Ophthalmic Solution (Development Code: RU-101) in US for the Treatment of Severe Dry Eye

R-Tech Ueno, Ltd. (JASDAQ:4573): This is to announce start of the patient enrollment of the first stage of a Phase I/II clinical study of recombinant human serum albumin-containing ophthalmic solution (development code: RU-101(Note 1); hereafter RU-101 ophthalmic solution), which is being developed in our company, in US for the treatment of...

Takeda's diabetes drug fasiglifam shines in Phase III

Takeda's diabetes drug fasiglifam shines in Phase III

Novo Nordisk reports positive results from Phase-3 haemophilia B study of N9-GP

Novo Nordisk has reported positive results from Phase-3 study of FIX derivative N9-GP to treat haemophilia B.

EpiCept Reports First Quarter 2013 Operating and Financial Results

PRELIMINARY PROXY STATEMENT FOR MERGER FILED WITH SEC Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced operating and financial results for the three months ended March 31, 2013, and provided an update on the Company’s planned merger with Immune Pharmaceuticals, Ltd. (Immune)....

Quest Diagnostics completes acquisition of Concentra's toxicology and clinical laboratory business

Quest Diagnostics, the world's leading provider of diagnostic information services, announced today that it has acquired the toxicology and clinical laboratory business of medical center operator Concentra, a subsidiary of Humana Inc.

[Health Policy] Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?

The need to align investments in health research and development (R&D) with public health demands is one of the most pressing global public health challenges. We aim to provide a comprehensive description of available data sources, propose a set...

SmithOnStocks Opines On Stocks: May 19th Edition

By Smith On Stocks: One Approach for Investing in Emerging Biotechnology Stocks I write on biotechnology and pharmaceutical companies of all sizes, but I have spent much of the last year focusing on small biotechnology companies ranging in size from as low as $50 million in market capitalization.to about $400 million. There is much less analyst and investor attention on these stocks, which can l...

CPAP May Help Glucose Control in Prediabetes (CME/CE)

PHILADELPHIA (MedPage Today) -- Prediabetic patients with obstructive sleep apnea had significant improvement in glucose levels after effective treatment with continuous positive airway pressure (CPAP), a small clinical trial showed.

Japan Medical Group To Prevent Repeats Of Tainted Novartis Diovan Trials

The Japanese Association of Medical Sciences has called a meeting to discuss ways to improve the nation's process of clinical trials in the wake of revelations Novartis studies of its Diovan (valsartan) blood-pressure drug may have been tainted.

Clinical Notes: Answer Emerges to MS Drug Puzzle

(MedPage Today) -- The mystery of why a drug for one autoimmune disease can cause another may have been solved. Also this week: a new oral nimodipine formulation aimed at reducing medication errors.

Managing Seasonal Allergies

SUNDAY, May 19 (HealthDay News) -- Although spring arrived late this year in parts of the United States, the summer allergy season will still be strong, according to a sinus expert at the University of Alabama at Birmingham. Dr. Richard Waguespack,...

Doctors Health Press Releases Statement on Peripheral Neuropathy in Honor of National Neuropathy Awareness Week

Doctors Health Press, a division of Lombardi Publishing Corporation and publisher of various natural health newsletters, books, and reports, including the popular online Doctors Health Press e-Bulletin, recently released a statement in honor of National Neuropathy Awareness Week, commenting on research surrounding peripheral neuropathy. Boston, MA (PRWEB) May 19, 2013 Doctors Health Press, a divi...

Roche's etrolizumab meets primary endpoint of clinical remission in moderate to severely active ulcerative colitis at week 10

Roche announced today that the EUCALYPTUS phase II induction study of etrolizumab in patients with moderate-to-severely active ulcerative colitis (UC) met its primary endpoint of clinical remission at week 10. Additionally, the data showed etrolizumab was well tolerated with no clinically significant safety concerns. Findings were presented this weekend at the 2013 Digestive Disease Week meeting h...

Lundbeck says drug shows improvement in depression symptoms

COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck and Japanese partner Takeda said on Saturday that data from clinical phase III studies with the antidepressant vortioxetine had shown significant improvement in patients' symptoms.

H. Lundbeck A/S: Vortioxetine clinical phase III data show significant improvement in symptoms of major depression

Vortioxetine clinical phase III data show significant improvement in symptoms of major depression -- Takeda and Lundbeck present results from pivotal phase III clinical trials with vortioxetine, an...

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Drug associated with rapid antidepressant effect in largest clinical trial to-date.

News digest – Angelina Jolie, clinical trial transparency, testicular cancer and more

Angelina Jolie’s decision to have a double mastectomy to reduce her risk of breast cancer, after she learnt she carried the BRCA1 gene, resulted in blanket coverage across the media this week. You can read about her reasons for undergoing … C...

Safety and efficacy evaluation methods for medical devices

Medical devices are any medical items that are neither a drug nor a biological product. In light of their different mechanisms, actions and regulatory requirements, medical device trail evaluations are much more complicated than drug trails due to th...

Interferential EMS Device Designed by Better Life Devices Now Offered by Rehabmart.com

Their popular Four Channel Clinical Interferential EMS Device provides the best attributes of muscle stimulation, pain relief, relaxation and muscle toning combined into one convenient and compact FDA-approved device. Also known as the BRUTE Analgesic Pulsar AP439™, this cutting edge medical product features multi waveforms which include interferential, Galvanic, Russian and TENS to fulfill a wi...

Pediatrics: HPV Warts Spread from Parents to Kids; polyDNA Recommends Protecting Kids from HPV with Gene-Eden VIR

Children often get warts from family members or classmates rather than from public spaces. (1) polyDNA suggests that parents use Gene-Eden-VIR to help prevent HPV transmission to their children. Rochester, NY (PRWEB) May 18, 2013 WebMD reports that “…a new Dutch study has found that the most likely way children get infected with the virus that causes warts is from close contact with family me...

EHRA EUROPACE 2013 to feature late breaking clinical trials

Attendees will have the opportunity to hear the results of cutting edge studies, and to learn about the new Guidelines which are likely to have a tremendous impact on the European health care system.

Six abstracts and clinical data on Cook Medical products to be presented at DDW 2013

At this week's Digestive Disease Week, the world's largest gathering of physicians and researchers in the gastroenterology field, six abstracts and other clinical data will be presented on Cook Medical products.

Alnylam reports pre-clinical data from ALN-AS1 program for treatment of AIP

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented key pre-clinical proof-of-concept data from its RNAi therapeutic program targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of porp...

Race, sex of study personnel influence patient's decision to participate in clinical research

Researchers at the University of Cincinnati have found that the race and sex of study personnel can influence a patient's decision on whether or not to participate in clinical research.

A Journey To Add Biotech To The Portfolio

ByGregory Stuckey:A Journey To Add Biotech To The PortfolioI recently evaluated my portfolio and realized I was completely invested in companies with market capitalizations over $100 billion. With what looks like a recovery to the overall economy of the US I wanted to reallocate some of my portfolio to gain exposure to small cap stocks. I have always been fascinated by the biotechnology industry a...